Skiplink Navigation

Main Features

Alleged pharma bribery Justice ministry confirms legal aid requests in Greece-Novartis scandal

A woman enters Novartis Greek offices in Athens, on Tuesday, Feb. 6, 2018.

Greece's government says it has evidence that senior politicians from the previous administration were involved in a bribery case in which Swiss drugmaker Novartis is accused of making illegal payments to fix prices and increase market access


Switzerland’s Federal Office of Justice has confirmed it has received two requests for legal assistance from Greece and the United States linked to probes into Novartis and alleged bribes involving the Swiss drugmaker and Greek doctors and public officials. 

The two requests for legal assistance linked to the Novartis-Greek scandal were received at the end of last year and in January 2018 and are being studied, a justice ministry official confirmed to Swiss public television, RTS, and the Swiss News Agency on Saturday.

+ Greek politicians named in Novartis scandal

The Greek parliament announced on Tuesday the results of a judicial investigation into alleged bribes paid to public officials by Basel-based Novartisexternal link over nearly a decade to boost subscriptions of their products at public hospitals. The ten prominent politicians linked to the bribery scandal include two former Greek prime ministers and eight former ministers. They are alleged to have been involved in approving Novartis contracts and overcharging in return for kickbacks. All deny the allegations.

Greece's Justice Minister Stavros Kontonis last year said Novartis had likely bribed "thousands" of doctors and civil servants to promote its products. He also accused Novartis of continuing to sell "overpriced" drugs even after the country was plunged into economic crisis in 2010 and huge cuts were imposed on state budgets, leaving many Greeks without access to affordable medicine. 

Novartis overcharges alone are estimated to have cost the Greek state some €3 billion euros ($3.7 billion). Overall, similar practises across the health sector cost Greece some €23 billion between 2000 and 2015, investigators have said.

The Greek branch of Novartis has issued a statement saying it was "aware of the media reports about our business practices" in Greece and that it was cooperating with the authorities, the Swiss News Agency said.


Neuer Inhalt

Horizontal Line

SWI on Instagram

SWI on Instagram

SWI on Instagram

subscription form

Form for signing up for free newsletter.

Sign up for our free newsletters and get the top stories delivered to your inbox.

Click here to see more newsletters